WEST PHARMACEUTICAL SERVICES, INC. Equity Securities, FV-NI, Unrealized Gain (Loss)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of -$2.20 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-07-28.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2024-02-20
- WEST PHARMACEUTICAL SERVICES, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2021-12-31 was -$2.40M.
- WEST PHARMACEUTICAL SERVICES, INC. equity securities, fv-ni, unrealized gain (loss) for fiscal 2021 was -$4.60M.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$2.20M 10-Q · filed 2022-07-28 | |||
| 2021-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$4.60M 10-K · filed 2024-02-20 | ||
| 2021-09-30 | -$2.20M 10-Q · filed 2022-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |